Chemokine saliva levels in patients with primary Sjögren's syndrome, associated Sjögren's syndrome, pre-clinical Sjögren's syndrome and systemic autoimmune diseases

Rheumatology

Volumn 50, Issue 7, 2011, Pages 1288-1292

  Hernández Molina, Gabriela ^a   Michel Peregrina, Martha ^a   Hernández Ramírez, Diego F ^a   Sánchez Guerrero, Jorge ^a   Llorente, Luis ^a  

^a INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

Author keywords

Chemokines; Saliva; Sj grens syndrome

Indexed keywords

CXCL13 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; STROMAL CELL DERIVED FACTOR 1;

ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; HUMAN; KRUSKAL WALLIS TEST; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANK SUM TEST; SALIVA ANALYSIS; SALIVA LEVEL; SJOEGREN SYNDROME; STATISTICAL ANALYSIS;

AUTOIMMUNE DISEASES; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHEMOKINE CXCL12; CHEMOKINE CXCL13; FEMALE; HUMANS; MALE; REFERENCE VALUES; SALIVA; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SJOGREN'S SYNDROME; STATISTICS, NONPARAMETRIC;

EID: 79959408729     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ker019     Document Type: Article

References (24)

1. Ramos-Casals M, Font J. Primary Sjögren's syndrome: current and emergent aetiopathogenic concepts. Rheumatology 2005;44:1354-67.
2. Ramos-Casals M, Solans R, Rosas J et al. Primary Sjögren syndrome in Spain. Clinical and immunologic expression in 1010 patients. Medicine 2008;87: 210-9.
3. Zodoray P, Alex P, Brun G, Centola M, Jonsson R. Circulating cytokines in primary Sjögren syndrome determined by a multiplex cytokine array system. Scand J Immunol 2004;59:592-9.
4. Wang F, Wang Q, Tang FL. Expression of chemokine in the labial glands of patients with Sjögren syndrome. Zhonghua Yi Xue Za Zhi 2003;83:220-3.
5. Cuello C, Palladinetti P, Tedla N, Di Girolamo N, Lloyd A, Wakefield D. Chemokine expression and leucocyte infiltration in Sjögren syndrome. Br J Rheumatol 1998;37: 779-83.
6. Xanthou G, Plihronis M, Tzioufas A, Pailos S, Sideras P, Moutsopoulos H. Lymphoid chemokine messenger RNA expression by epithelial cells in the chronic inflammatory lesion of the salivary glands of Sjögren syndrome patients. Arthritis Rheum 2001;44:408-18.
7. Ogawa N, Kawanami T, Shimoyama K, Ping L, Sugai S. Expression of interferon-inducible T cell a chemoattractant (CXCL11) in the salivary glands of patients with Sjögren's syndrome. Clin Immunol 2004;112:235-8.
8. Sfriso P, Oliviero F, Calabrese F et al. Epithelial CXCR3-B regulates chemokines bioavailability in normal, but not in Sjögren's syndrome, salivary glands. J Immunol 2006;176: 2581-9.
9. Barone F, Bombardierei M, Manzo A et al. Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjögren syndrome. Arthritis Rheum 2005;52:1773-84.
10. Amft N, Curnow J, Scheel D et al. Ectopic expression of the B-cell attracting chemokine BCA-1 (CXCL13) in endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sjögren's syndrome. Arthritis Rheum 2001; 44:2633-41.
11. Salomonsson S, Larsson P, Tengner P, Mellquist E, Hjelmstrom P, Herlenius W. Expression of the B cell-attracting chemokine CXCL13 in the target organ and autoantibody production in ectopic lymphoid tissue in the chronic inflammatory disease Sjögren's syndrome. Scand J Immunol 2002;55:336-42.
12. Herná ndez-Molina G, Á vila-Casado C, Cá rdenas-Velá zquez F et al. Similarities and differences between primary and secondary Sjögren's syndrome. J Rheumatology 2010;37:800-8.
13. Vitali C, Bombardiere S, Jonsson R et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61: 554-8.
14. Smith PK, Krohn RI, Hermanson GT et al. Measurement of protein using bicinchoninic acid. Anal Biochem 1985;150: 76-85.
15. Delaleu N, Immervoll H, Cornelius J, Jonsson R. Biomarker profiles in serum and saliva of experimentalSjögren's syndrome: associations with specific autoimmune manifestations. Arthritis Res Ther 2008;10: R22.
16. Lee Y, Scofield R, Young J et al. Salivary chemokine levels in patients with primary Sjögren's syndrome. Rheumatology 2010;49:1747-52.
17. Tisher M, Yaron I, Shirazi I, Yaron M. Saliva: an additional diagnostic tool in Sjögren's syndrome. Semin Arthritis Rheum 1997;27:173-9.
18. Baldini C, Giusti L, Bazzichi L, Luachini A, Bombardieri S. Proteomic analysis of the saliva: a clue for understanding primary from secondary Sjögren's syndrome? Autoimmun Rev 2008;7:185-91.
19. Lee E, Lee Z, Song Y. CCXCL10 and autoimmune diseases. Autoimmun Rev 2009;8:379-83.
20. Daly C, Rollins B. Monocyte chemoattractant protein-1 (CCL2) in inflammatory disease and adaptive immunity: therapeutic opportunities and controversies. Microcirculation 2003;10:247-57.
21. Deshmane S, Kremiev S, Amini S, Sawaya B. Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res 2009;29:313-26.
22. Rantappa-Dahlqvist S, Boman K, Tarkowski A, Hallmans G. Up regulation of monocyte chemoattractant protein-1 expression in anti-citrulline antibody and immunoglobulin M rheumatoid factor positive subjects precedes onset of inflammatory response and development of overt rheumatoid arthritis. Ann Rheum Dis 2007; 66:121-3.
23. Hansen A, Lipsky P, Dömer T. B cells in Sjögren's syndrome: indications for disturbed selection and differentiation in ectopic lymphoid tissue. Arthritis Res Ther 2007;9:218.
24. Hasegawa M, Inoue A, Kohno M, Muraoka M, Miyazaki T, Terada M. Antagonist of interferon-inducible protein 10/CXCL10 ameliorates the progression of autoimmune sialadenitis in MRL/lpr mice. Arthritis Rheum 2006;54: 1174-83.